phase 1
study 2
idelalisib 1
entospletinib 1
pneumonitis 1
limits 1
combination 1
therapy 1
relapsed 1
refractory 1
cll 1
nhl 1
investigation 1
dynamic 1
bending 1
properties 1
mos 1
thin 1
films 1
interference 1
colours 1
depression 1
care 2
management 1
adults 1
older 1
years 1
primary 1
clinics 1
urban 1
china 1
clusterrandomised 1
trial 1
targeted 1
nextgeneration 1
sequencing 1
comprehensive 1
test 1
patients 1
female 1
carriers 1
dmdbmd 1
multipopulation 1
diagnostic 1
